NCT00497458View on ClinicalTrials.gov

Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects

PHASE2UnknownINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

June 30, 2009

Conditions

Breast CancerArthralgiaOsteoporosis

Interventions

DRUG

Testosterone

testosterone 40 or 80 mg once a day

Trial Locations (1)

Unknown

Burnside Breast Centre, Adelaide

Sponsors

Lead Sponsor

Havah Therapeutics Pty Ltd

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Havah Therapeutics Pty Ltd

INDUSTRY